Business Context and Reporting Period
This Form 8-K is filed by Oramed Pharmaceuticals Inc., a Nevada corporation, with a report date of March 31, 2008. The filing primarily addresses a change in the registrant's certifying accountant.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. However, it notes that the outgoing auditor, Malone & Bailey, PC, included an explanatory paragraph in their opinions for the two most recent fiscal years describing conditions that raised substantial doubt about the Company's ability to continue as a going concern.
Material Changes
- Dismissal of Auditor: On March 31, 2008, the Board of Directors dismissed Malone & Bailey, PC ("M&B").
- Appointment of New Auditor: Effective April 1, 2008, the Board retained PricewaterhouseCoopers LLC ("PwC") as the new independent registered public accounting firm for the fiscal year ending August 31, 2008.
- Internal Control Issues: The filing references a discussion with M&B regarding a lack of effective internal controls. This followed M&B's identification of equity adjustments and a disclosure omission during the audit process, which were subsequently adjusted and disclosed in the Form 10-KSB for the year ended August 31, 2007.
Outlook, Risks, and Management Commentary
- Going Concern Risk: The prior auditor's reports highlighted substantial doubt regarding the company's ability to continue as a going concern.
- Remediation Efforts: Management and directors reported they were in the process of improving disclosure and internal controls to remediate identified deficiencies and were working with auditors and outside advisors to ensure controls are adequate.
- No Disagreements: The Company stated there were no disagreements with M&B on accounting principles, practices, or auditing scope that would have required reference in the auditor's report.
- No Prior Consultation: The Company confirmed it did not consult PwC regarding accounting principles or audit opinions during the two most recent fiscal years prior to their engagement.
Investor Verification Checklist
- Verify the status of the "substantial doubt" regarding the company's ability to continue as a going concern.
- Review the Form 10-KSB for the year ended August 31, 2007, for details on the equity adjustments and disclosure omissions.
- Confirm the progress of internal control remediation efforts mentioned by management.
- Examine the letter from Malone & Bailey, PC (Exhibit 16.1) for any additional context on the dismissal.